SINGAPORE-BASED biotech company Tessa Therapeutics and China-Singapore Guangzhou Knowledge City (CSGKC) have formed a US$120 million joint venture (JV) in China to develop cell therapies for...

IN a sign that it could be progressing towards certain milestones, Singapore-based immunotherapy biotech company Tessa Therapeutics continued to shore up its board of directors with another...